Data / Form D filings / Checkpoint Therapeutics, Inc.
Checkpoint Therapeutics, Inc.: Form D filings
Checkpoint Therapeutics, Inc., a biotechnology company in Waltham, MA, filed 5 Form D notices with the SEC between 2016 and 2024. The latest, on July 10, 2024, reports an offering of no set size with nothing sold yet to 1 investor.
SpecStream is the live web data engine for teams and agents. It reads every Form D on SEC EDGAR the day it is filed, and this page is that reading. Ask for your own cut (a state, an industry, a size) and new filings arrive in your sheet, CRM, Slack or agent as they land.
Company details from the filing
- Address
- 95 SAWYER ROAD, SUITE 110, Waltham, MA, 02453
- Phone
- (781) 652-4500
- Industry
- Biotechnology
- Entity type
- Corporation
- Incorporated in
- Delaware
- Revenue range
- Decline to Disclose
- Exemptions claimed
- Rule 506(b)
- SEC identifier (CIK)
- 1651407
Form D filings
| Filed | Type | Offering | Sold | Remaining | Investors | First sale | Filing |
|---|---|---|---|---|---|---|---|
| Jul 10, 2024 | New notice | Indefinite | $0 | 1 | Jul 2, 2024 | sec.gov | |
| Feb 5, 2024 | New notice | Indefinite | $0 | 1 | Jan 27, 2024 | sec.gov | |
| Apr 14, 2023 | New notice | Indefinite | $0 | 9 | Mar 30, 2023 | sec.gov | |
| Mar 3, 2023 | New notice | Indefinite | $0 | 1 | Feb 22, 2023 | sec.gov | |
| Sep 13, 2016 | New notice | $62,500,000 | $57,817,000 | $4,683,000 | 559 | Sep 30, 2015 | sec.gov |
Executive officers and directors named in the filing
| Name | Role | Note in the filing |
|---|---|---|
| Barry F. Salzman | Director | |
| Michael F. Weiss | Director | |
| Amit A. Sharma | Director | |
| Neil F. Herskowitz | Director | |
| Christian F. Bechon | Director | |
| Lindsay A. Rosenwald | Director | |
| James F. Oliviero, III | Executive Officer, Director | |
| Garrett F. Gray | Executive Officer |
Other biotechnology companies in Massachusetts that filed recently
- Tru Singular Health, Inc. $1 million · Oct 30, 2026
- 511 Therapeutics, Inc. $500,000 · Oct 30, 2026
- Elucid Bioimaging Inc. $56.2 million · Oct 27, 2026
- OrthoIQ, Inc. $1.1 million · Oct 23, 2026
- LeanBio Therapeutics, Inc. offering · Oct 22, 2026
- Quiver Holdings Inc. $3 million · Oct 21, 2026
Every Form D from the week of Jul 8, 2024 · All recent filings in Massachusetts · All recent Biotechnology filings
Read from SEC EDGAR. Amount sold is what Checkpoint Therapeutics, Inc. reported on the day it filed; on an offering that is still open, a later amendment can raise it. Free to reuse with credit to SpecStream under CC BY 4.0.